Methenamine Hippurate Tablet
Product Images NDC 50268-549

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Methenamine Hippurate (NDC 50268-549). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avpak, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1g (549 15 1g 50ct)

This is a prescription-only medication with the NDC code 50268-549-15, containing methenamine hippurate in tablet form. Each tablet contains 1 g of methenamine hippurate, USP. The package contains 50 tablets arranged in a 5 x 10 Unit Dose format. The instructions for use are available in the package insert. It is important to store the tablets between 20°C to 25°C (68°F to 77°F), with temperature excursions permitted between 15° and 30°C (59°F to 86°F), and to keep the drugs out of reach of children. The manufacturer of the drug is AVKARE, located in Pulaski, TN 38478.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.